Abstract
THE symptoms of Huntington's chorea, an hereditary movement disorder, result from degeneration of neurones primarily in the basal ganglia1. Several neurochemical abnormalities have been identified in the brains of patients dying with this disorder2–5, but no animal system with similar neuropathological changes has been described. We now report that the injection of kainic acid into the rat striatum causes neuronal degeneration, neurochemical alterations and behavioural responses resembling Huntington's chorea. This procedure could provide an animal model for the study of the disease.
This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
Krankheitsmodifizierende Therapieansätze bei der Huntington-Krankheit
Der Nervenarzt Open Access 11 November 2021
-
Quantitative proteomic analyses of dynamic signalling events in cortical neurons undergoing excitotoxic cell death
Cell Death & Disease Open Access 01 March 2019
Access options
Subscribe to this journal
Receive 51 print issues and online access
$199.00 per year
only $3.90 per issue
Rent or buy this article
Get just this article for as long as you need it
$39.95
Prices may be subject to local taxes which are calculated during checkout
References
Bruyn, G. W., in Handbook of Clinical Neurology, Diseases of Basal Ganglia, 6, (edit. by Vinken, P. J., and Bruyn, G. W.), 298–377 (North-Holland, Amsterdam, 1968).
Perry, T. L., Hansen, S., and Kloster, M., New Engl. J. Med., 288, 337–342 (1973).
Bird, E. D., and Iversen, L. L., Brain, 97, 457–472 (1974).
McGeer, P. L., and McGeer, E. G., J. Neurochem., 26, 65–76 (1976).
Stahl, W. L., and Swanson, P. D., Neurology, 24, 813–819 (1974).
Lucas, D. R., and Newhouse, J. P., Am. med. Ass. Archs Opthal, 58, 193–204 (1957).
Olney, J. W., Science, 164, 719–721 (1969).
Perez, V. J., and Olney, J. W., J. Neurochem., 19, 1777–1782 (1972).
Olney, J. W., Schainker, B., and Rhee, V., in Hormones, Behavior and Psychopathology (edit. by Sachar, E.), 153–158 (Raven, New York, 1976).
Olney, J. W., Rhee, V., and Ho, O. L., Expl Brain Res., 14, 61–76 (1972).
Zieglgansberger, W., and Puil, E. A., Expl Brain Res., 17, 35–49 (1973).
Buu, N. T., and Van Gelder, N. M., Gen. Pharmac., 7, 5–14 (1976).
Olney, J. W., Rhee, V., and Ho, O. L., Brain Res., 77, 507–512 (1974).
Van Harreveld, A., and Fifova, E., Expl molec. Path., 15, 61–81 (1971).
Olney, J. W., Sharpe, L. G., and de Gubareff, T., Neurosci. Abstr., 1, 371 (1975).
McGeer, P. L., and McGeer, E. G., in GABA in Nervous System Function (edit. by Roberts, E., Chase, T. N., and Tower, D. B.), 487–496 (Raven, New York, 1976).
Glowinski, J., and Iversen, L. L., J. Neurochem., 13, 655–669 (1966).
McLennan, H., in Handbook of Psychopharmacology: Amino Acid Neurotransmitters, 4 (edit. by Iversen, L. L., Iversen, S. D., and Snyder, S. H.), 211–228 (Plenum, New York, 1975).
Javoy, F., Sotelo, C., Herbert, A., and Agid, Y., Brain Res., 102, 201–215 (1976).
Fonnum, F., Grofora, I., Rinvik, E., Storm-Mathiesen, J., and Walburg, F., Brain Res., 71, 77–92 (1974).
Ungerstedt, U., Acta physiol. scand., Suppl., 367, 1–22 (1971).
Racagni, G., Cheney, D. L., Trabucchi, M., and Costa, E., J. Pharmac. exp. Ther., 196, 323–332 (1976).
Coyle, J. T., Biochem. Pharmac., 21, 1935–1944 (1972).
Bull, G., and Oderfeld-Nowak, B., J. Neurochem., 19, 935–947 (1971).
Wilson, S. H., et al., J. biol. Chem., 247, 3159–3169 (1972).
Graham, L. T., and Aprison, M. H., Analyt. Biochem., 15, 487–497 (1966).
Goldberg, A. M., and McCamman, R. E., J. Neurochem., 20, 1–8 (1973).
Coyle, J. T., and Henry, D., J. Neurochem., 21, 61–67 (1973).
Lowry, O. H., Rosebrough, N. J., Farr, A. L., and Randall, P. J., J. biol. Chem., 193, 265–275 (1975).
Coyle, J. T., and Enna, S. J., Brain Res. 111, 119–133 (1976).
Simon, J. R., Atweh, S., and Kuhar, M. J., J. Neurochem., 26, 909–922 (1976).
Holz, R. W., and Coyle, J. T., Molec. Pharmac., 10, 746–758 (1974).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
COYLE, J., SCHWARCZ, R. Lesion of striatal neurons with kainic acid provides a model for Huntington's chorea. Nature 263, 244–246 (1976). https://doi.org/10.1038/263244a0
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/263244a0
This article is cited by
-
Krankheitsmodifizierende Therapieansätze bei der Huntington-Krankheit
Der Nervenarzt (2022)
-
Quantitative proteomic analyses of dynamic signalling events in cortical neurons undergoing excitotoxic cell death
Cell Death & Disease (2019)
-
Protective Effects of Antioxidants in Huntington’s Disease: an Extensive Review
Neurotoxicity Research (2019)
-
Cell-Autonomous and Non-cell-Autonomous Pathogenic Mechanisms in Huntington’s Disease: Insights from In Vitro and In Vivo Models
Neurotherapeutics (2019)
Comments
By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.